Century Capital Management’s NeoGenomics NEO Stock Holding History

Century Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$1.05M	Sell	117,762 -1,950	-2%	-$15.5K	0.18%	158
2017 Q1	$945K	Sell	119,712 -2,551	-2%	-$20.8K	0.15%	179
2016 Q4	$1.05M	Buy	+122,263	New	+$1.05M	0.14%	180

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Century Capital Management's NEO Position: Q2 2017 in Review

Century Capital Management reduced its NeoGenomics (NEO) stake by 1.6% in Q2 2017, selling an estimated $15.5K and leaving 117,762 shares worth $1.05M. The position accounts for 0.18% of the portfolio, ranked #158.

Century Capital Management first reported a position in NEO in Q4 2016 and has held it in 3 quarters since. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

Century Capital Management held 117,762 shares of NeoGenomics worth $1.05M as of Q2 2017.
Century Capital Management sold 1,950 NeoGenomics shares in Q2 2017, an estimated $15.5K.
NeoGenomics made up 0.18% of Century Capital Management's portfolio in Q2 2017, its #158 holding.
Century Capital Management first reported a position in NeoGenomics in Q4 2016 and has held it in 3 quarters since.
134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Century Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.